Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
30-Jun-2021
Change in substantial holding
29-Jun-2021
Cleansing Statement
29-Jun-2021
Confirmation of Capital Structure, CDIs on Issue
29-Jun-2021
Notification regarding unquoted securities - NYR
29-Jun-2021
Application for quotation of securities - NYR
29-Jun-2021
Application for quotation of securities - NYR
29-Jun-2021
NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
16-Jun-2021
Results of Meeting
15-Jun-2021
Improved Drug Candidate Selected for WRAIR Studies
11-May-2021
Notice of Extraordinary General Meeting/Proxy Form
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
